Pan-cancer analysis of plasmacytoma variant translocation 1 and <i>MYC</i> gene expression pattern and survival prediction

Abstract

Abstract:

Objective:To explore the expression levels and survival prediction of plasmacytoma variant translocation 1 (PVT1) andMYCgene in pan-cancer.Methods:The clinic data and RNA-seq data from 31 types of cancer tissues totaling 10 016 cases were retrieved from The Cancer Genome Atlas (TCGA) database, among which 23 types of cancer with adjacent tissues as normal controls. Studentt-tests were used to analyze the significant differences ofPVT1orMYCgene expression levels between cancer tissues and corresponding normal controls. Spearman correlation was used to analyze the expression correlation betweenPVT1andMYCin 31 types of cancer. The relationship betweenPVT1orMYCexpression and overall survival of 31 types of cancer patients was depicted by the Kaplan-Meier curve and Cox proportional hazards model.Results:=PVT1expression was highly expressed in 19 types of cancer(P<0.05) and lowly expressed in 2 types of cancer (P<0.05).MYCexpression was significantly upregulated in 7 types of cancer (P<0.05) and downregulated in 6 types of cancer (P<0.05). Expression correlation analysis presented thatPVT1expression was positively correlated withMYCin about 87% (27/31) types of cancer (Rho>0,P<0.01). Finally, survival analysis showed that relatively high expression ofPVT1was significantly associated with shorter overall survival in bladder urothelial carcinoma, breast invasive carcinoma, adrenocortical carcinoma, renal clear cell carcinoma, renal papillary cell carcinoma, lower grade glioma, prostate adenocarcinoma, testicular germ cell tumors and uveal melanoma (log-rankP<0.05). The relatively high expression group ofMYCwas significantly correlated with shorter overall survival in adrenocortical carcinoma, bladder urothelial carcinoma, cervical squamous cell carcinoma, head and neck squamous cell carcinoma, renal papillary cell carcinoma, ovarian serous cystadenocarcinoma, pancreatic adenocarcinoma and sarcoma (log-rankP<0.05), while was associated with long-time survival in lower grade glioma and rectum adenocarcinoma (log-rankP<0.05).Conclusions:The increased expression ofPVT1in pan-cancer is more prevalent than that ofMYC. The positive correlation betweenPVT1andMYCindicates a potential regulatory relationship in cancers. Furthermore, the relatively high expression ofPVT1has a poor effect on the overall survival of patients in 9 types of cancer, while the expression level ofMYCpresents different effects on the overall survival of patients in various cancers.

Key words:Plasmacytoma variant translocation 1 gene,MYCgene,Tumor,Survival time

CLC Number:

R541.7

MA Xuefei, WANG Xuefeng, WANG Kankan. Pan-cancer analysis of plasmacytoma variant translocation 1 andMYCgene expression pattern and survival prediction[J]. Journal of Diagnostics Concepts & Practice, 2022, 21(04): 490-496.

Figures/Tables5

肿瘤类型	英文全称	中文名称	正常样本数量	肿瘤样本数量	表达差异P值	肿瘤中表达
BLCA	Bladder urothelial carcinoma	膀胱尿路上皮细胞癌	19	414	<0.001	升高
BRCA	Breast invasive carcinoma	乳腺浸润癌	113	1 102	<0.001	升高
CESC	Cervical squamous cell carcinoma	宫颈鳞状细胞癌	3	304	<0.001	升高
CHOL	Cholangiocarcinoma	胆管癌	9	36	<0.001	升高
COAD	Colon adenocarcinoma	结肠腺癌	41	478	<0.001	升高
ESCA	Esophageal carcinoma	食管癌	11	161	<0.001	升高
GBM	Glioblastoma multiforme	多形性胶质母细胞瘤	5	156	<0.001	升高
HNSC	Head and neck squamous cell carcinoma	头颈部鳞状细胞癌	44	500	<0.001	升高
KICH	Kidney chromophobe	肾嫌色细胞癌	24	65	0.022	升高
KIRC	Kidney renal clear cell carcinoma	肾透明细胞癌	72	538	<0.001	升高
KIRP	Kidney renal papillary cell carcinoma	乳头状肾细胞癌	32	288	<0.001	升高
LIHC	Liver hepatocellular carcinoma	肝细胞癌	50	371	<0.001	升高
LUAD	Lung adenocarcinoma	肺腺癌	59	533	<0.001	升高
LUSC	Lung squamous cell carcinoma	肺鳞状细胞癌	49	502	<0.001	升高
PAAD	Pancreatic adenocarcinoma	胰腺癌	4	177	0.762	无统计学意义
PRAD	Prostate adenocarcinoma	前列腺癌	51	498	<0.001	升高
PCPG	Pheochromocytoma and paraganglioma	嗜铬细胞瘤和副神经节瘤	3	178	0.001	降低
READ	Rectum adenocarcinoma	直肠腺癌	10	166	<0.001	升高
SARC	Sarcoma	肉瘤	2	259	0.178	无统计学意义
STAD	Stomach adenocarcinoma	胃腺癌	32	375	<0.001	升高
THCA	Thyroid carcinoma	甲状腺癌	58	502	0.046	降低
THYM	Thymoma	胸腺瘤	2	119	<0.001	升高
UCEC	Uterine corpus endometrial carcinoma	子宫内膜癌	35	551	<0.001	升高

Cancer types	中文名称	数量（相对高表达组）	数量（相对低表达组）	Log-rankP值	HR (high)	P(HR)值
ACC	肾上腺皮质癌	38	38	1.7E-4	4.9	6.3E-4
BLCA	膀胱尿路上皮细胞癌	201	201	8.8E-3	1.5	9.2E-3
CESC	宫颈鳞状细胞癌	146	146	3.9E-3	2	4.6E-3
HNSC	头颈部鳞状细胞癌	259	259	0.028	1.3	0.029
KIRP	乳头状肾细胞癌	141	141	0.041	1.9	0.046
LGG	低级别胶质瘤	257	257	2.6E-3	0.58	2.9E-3
OV	卵巢浆液性囊腺癌	212	212	0.029	1.3	0.029
PAAD	胰腺癌	89	89	8.5E-3	1.7	9.1E-3
READ	直肠腺癌	46	46	0.014	0.29	0.021
SARC	肉瘤	131	131	0.004	1.8	4.7E-3

References25

[1]	Jiang N, Zhang X, Gu X, et al. Progress in understanding the role of lncRNA in programmed cell death[J]. Cell Death Discov, 2021, 7(1):30. doi:10.1038/s41420-021-00407-1pmid:33558499
[2]	Wang W, Min L, Qiu X, et al. Biological function of long non-coding RNA (LncRNA) xist[J]. Front Cell Dev Biol, 2021, 9:645647.
[3]	McCabe EM, Rasmussen TP. lncRNA involvement in cancer stem cell function and epithelial-mesenchymal transitions[J]. Semin Cancer Biol, 2021, 75:38-48. doi:10.1016/j.semcancer.2020.12.012pmid:33346133
[4]	Jin K, Wang S, Zhang Y, et al. Long non-coding RNA PVT1 interacts with MYC and its downstream molecules to synergistically promote tumorigenesis[J]. Cell Mol Life Sci, 2019, 76(21):4275-4289. doi:10.1007/s00018-019-03222-1pmid:31309249
[5]	Tseng YY, Moriarity BS, Gong W, et al. PVT1 dependence in cancer with MYC copy-number increase[J]. Nature, 2014, 512(7512):82-86. doi:10.1038/nature13311 URL
[6]	Chandrashekar DS, Bashel B, Balasubramanya SAH, et al. UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses[J]. Neoplasia, 2017, 19(8):649-658. doi:S1476-5586(17)30179-3pmid:28732212
[7]	Li B, Severson E, Pignon JC, et al. Comprehensive analyses of tumor immunity: implications for cancer immunotherapy[J]. Genome Biol, 2016, 17(1):174. doi:10.1186/s13059-016-1028-7pmid:27549193
[8]	Li T, Fan J, Wang B, et al. TIMER: a web server for comprehensive analysis of tumor-infiltrating immune cells[J]. Cancer Res, 2017, 77(21):e108-e110. doi:10.1158/0008-5472.CAN-17-0307 URL
[9]	Li T, Fu J, Zeng Z, et al. TIMER2.0 for analysis of tumor-infiltrating immune cells[J]. Nucleic Acids Res, 2020, 48(W1):W509-W514. doi:10.1093/nar/gkaa407 URL
[10]	Tang Z, Li C, Kang B, et al. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses[J]. Nucleic Acids Res, 2017, 45(W1):W98-W102. doi:10.1093/nar/gkx247 URL
[11]	Cancer Genome Atlas Research Network, Weinstein JN, Collisson EA, et al. The cancer genome atlas pan-cancer analysis project[J]. Nat Genet, 2013, 45(10):1113-1120. doi:10.1038/ng.2764pmid:24071849
[12]	Espinoza I, Agarwal S, Reddy A, et al. Expression of trefoil factor 3 is decreased in colorectal cancer[J]. Oncol Rep, 2021, 45(1):254-264. doi:10.3892/or.2020.7829pmid:33210724
[13]	Huang S, Li D, Zhuang L, et al. Identification of Arp2/3 complex subunits as prognostic biomarkers for hepatocellular carcinoma[J]. Front Mol Biosci, 2021, 8:690151. doi:10.3389/fmolb.2021.690151 URL
[14]	Luan W, Ding Y, Ma S, et al. Long noncoding RNA LIN 00518 acts as a competing endogenous RNA to promote the metastasis of malignant melanoma via miR-204-5p/AP1S2 axis[J]. Cell Death Dis, 2019, 10(11):855. doi:10.1038/s41419-019-2090-3 URL
[15]	Yang YR, Zang SZ, Zhong CL, et al. Increased expression of the lncRNA PVT1 promotes tumorigenesis in non-small cell lung cancer[J]. Int J Clin Exp Pathol, 2014, 7(10):6929-6935.
[16]	Guo J, Hao C, Wang C, et al. Long noncoding RNA PVT1 modulates hepatocellular carcinoma cell proliferation and apoptosis by recruiting EZH2[J]. Cancer Cell Int, 2018, 18:98. doi:10.1186/s12935-018-0582-3pmid:30008615
[17]	Tang J, Li Y, Sang Y, et al. LncRNA PVT1 regulates triple-negative breast cancer through KLF5/beta-catenin signaling[J]. Oncogene, 2018, 37(34):4723-4734. doi:10.1038/s41388-018-0310-4pmid:29760406
[18]	Zhao J, Du P, Cui P, et al. LncRNA PVT1 promotes angiogenesis via activating the STAT3/VEGFA axis in gastric cancer[J]. Oncogene, 2018, 37(30):4094-4109. doi:10.1038/s41388-018-0250-zpmid:29706652
[19]	Fang J, Huang J. Clinical significance of the expression of long non-coding RNA PVT1 in glioma[J]. Cancer Biomark, 2019, 24(4):509-513. doi:10.3233/CBM-182253pmid:30909189
[20]	Wu H, Wei M, Jiang X, et al. lncRNA PVT1 Promotes tumorigenesis of colorectal cancer by stabilizing miR-16-5p and interacting with the VEGFA/VEGFR1/AKT Axis[J]. Mol Ther Nucleic Acids, 2020, 20:438-450. doi:10.1016/j.omtn.2020.03.006 URL
[21]	Zhou C, Yi C, Yi Y, et al. LncRNA PVT1 promotes gemcitabine resistance of pancreatic cancer via activating Wnt/β-catenin and autophagy pathway through modula-ting the miR-619-5p/Pygo2 and miR-619-5p/ATG14 axes[J]. Mol Cancer, 2020, 19(1):118. doi:10.1186/s12943-020-01237-y URL
[22]	Schaub FX, Dhankani V, Berger AC, et al. Pan-cancer alterations of the MYC oncogene and its proximal network across the cancer genome atlas[J]. Cell Syst, 2018, 6(3):282-300. doi:S2405-4712(18)30097-8pmid:29596783
[23]	Duffy MJ, O'Grady S, Tang M, et al. MYC as a target for cancer treatment[J]. Cancer Treat Rev, 2021, 94:102154.
[24]	Shigeyasu K, Toden S, Ozawa T, et al. The PVT1 lncRNA is a novel epigenetic enhancer of MYC, and a promising risk-stratification biomarker in colorectal cancer[J]. Mol Cancer, 2020, 19(1):155. doi:10.1186/s12943-020-01277-4pmid:33148262
[25]	Zhang MX, Zhang LZ, Fu LM, et al. Positive feedback regulation of lncRNA PVT1 and HIF2α contributes to clear cell renal cell carcinoma tumorigenesis and metastasis[J]. Oncogene, 2021, 40(37):5639-5650. doi:10.1038/s41388-021-01971-7 URL

Pan-cancer analysis of plasmacytoma variant translocation 1 andMYCgene expression pattern and survival prediction

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables5

References25

Related Articles15

Recommended Articles

Metrics

Comments

[1]	WANG Zhiqian, LI Min, YÜ Yifei, ZHOU Jianqiao.Ultrasonographic characteristics of testicular adrenal residue tumor in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency[J]. Journal of Diagnostics Concepts & Practice, 2022, 21(05): 588-591.
[2]	GU Xuan, LIU Jun.Ultrasound screening to identify solid pseudopapillary tumours of the pancreas from pancreatic ductal adenocarcinoma[J]. Journal of Diagnostics Concepts & Practice, 2022, 21(04): 504-508.
[3]	HE Xin, CHEN Hui, FENG Weiwei.Research progress on the application of machine learning in assisted ultrasound diagnosis of adnexal masses[J]. Journal of Diagnostics Concepts & Practice, 2022, 21(04): 541-546.
[4]	GUO Yebing, ZHENG Jinfeng.The extra-gastrointestinal stromal tumors located in vagina: A case report and literature review[J]. Journal of Diagnostics Concepts & Practice, 2022, 21(03): 405-407.
[5]	YANG Bowen, JIANG Meijiao, CHEN Hui.Study on differential diagnosis of malignant and benign ovarian tumors through IOTA simple rules[J]. Journal of Diagnostics Concepts & Practice, 2022, 21(01): 74-79.
[6]	ZHANG Hua, LU Wei, YANG Chengyi, XIANG Mingjie.Value of serum FBLN1 detection in diagnosis and prognosis prediction of colorectal cancer[J]. Journal of Diagnostics Concepts & Practice, 2021, 20(05): 462-465.
[7]	GU Yijin, LI Anqi, DONG Lei, XU Haimin, SHEN Xia, XIE Jialing, YUAN Fei, WANG Chaofu.Correlation ofKITandPDGFRAmutation status with clinicopathologic features in primary and recurrent or metastatic gastrointestinal stromal tumors[J]. Journal of Diagnostics Concepts & Practice, 2021, 20(03): 257-264.
[8]	AN Xiaoning, WEI Zhaonan, SHEN Yan, SHI Hao, ZHANG Wen, CHEN Yongxi.Effects of macrophages depletion on lipopolysaccharide-induced renal and extra-renal inflammatory response in mice[J]. Journal of Diagnostics Concepts & Practice, 2021, 20(02): 195-200.
[9]	JIN Jiaoying, JIANG Xiao, XU Ang, ZHANG Changbao, LI Qianyu.Liposclerosing myxofibrous tumor: clinicopathologic analysis of 10 cases and review of literature[J]. Journal of Diagnostics Concepts & Practice, 2020, 19(06): 577-582.
[10]	ZHONG Ming, ZHAO Feng, WU Yan, PEI Wenjiang, GAO Hang, GUO Shanyu, DAI Qiancheng, ZHANG Wei.Establishment of a detection method for tumor suppressor geneHIC-1methylation in cell-free DNA and its significance in diagnosis of breast diseases[J]. Journal of Diagnostics Concepts & Practice, 2019, 18(2): 144-148.
[11]	HAN Dongyan, FU Huijun, HE Yanyan, XI Hao, WEI Qing.Endolymphatic sac tumor: Clinicopathological features and review of literature[J]. Journal of Diagnostics Concepts & Practice, 2018, 17(06): 711-714.
[12]	CHEN Xiaoyan, YANG Xiaoqun, YUAN Fei, ZHANG Jing, WANG Chaofu.Pulmonary ciliated muconodular papillary tumor: clinical pathologic analysis of two cases and review of literature[J]. Journal of Diagnostics Concepts & Practice, 2018, 17(05): 575-580.
[13]	YAO Yulan, GUO Enwei, REN Dali, ZHANG Bingyu, YANG Feng, CHEN Qing, LIU Xinghui, LUO Qiancheng, FENG Gang.Correlation of serum interleukin 33 and soluble suppression of tumorigenicity 2 with injury severity and prognosis in trauma patients[J]. Journal of Diagnostics Concepts & Practice, 2018, 17(03): 299-303.
[14]	MAO Minjing, ZHANG Binbin, YE Tingjun, WANG Xuefeng.Significance of macrophage count in fine needle aspirate cytology smear from papillary thyroid carcinoma[J]. Journal of Diagnostics Concepts & Practice, 2018, 17(01): 56-59.
[15]	ZHU Peipei, ZOU Jue, CHEN Jun, XU Rongrong, YAN Hongzhu.Intracranial solitary fibrous tumor/hemangiopericytoma: a clinicopathologic study of 20 cases with review of literature[J]. Journal of Diagnostics Concepts & Practice, 2017, 16(06): 622-626.